Treatment of infants identified as having severe combined immunodeficiency by means of newborn screening  Morna J. Dorsey, MD, MMSc, Christopher C. Dvorak,

Slides:



Advertisements
Similar presentations
Control of immunopathology during chikungunya virus infection Caroline Petitdemange, PhD, Nadia Wauquier, PhD, Vincent Vieillard, PhD Journal of Allergy.
Advertisements

Jonathan A. Bernstein, MD, David M. Lang, MD, David A. Khan, MD 
What drives prescription patterns in pediatric asthma management?
The natural history of soy allergy
Doina M. Racila, MD, Joel N. Kline, MD, MSc 
Newborn screening for severe combined immunodeficiency and T-cell lymphopenia in California: Results of the first 2 years  Antonia Kwan, PhD, MRCPCH,
Laboratory technology for population-based screening for severe combined immunodeficiency in neonates: The winner is T-cell receptor excision circles 
Jessica P. Hollenbach, PhD, Michelle M. Cloutier, MD 
Advances in food allergy in 2015
Santa Jeremy Ono, BA, PhD, Mark B. Abelson, MD 
F. Estelle R. Simons, MD, FAAAAI, Hugh A. Sampson, MD, FAAAAI 
David A. Khan, MD  Journal of Allergy and Clinical Immunology 
Long-term immune reconstitution after matched unrelated hematopoietic stem cell transplantation for immunodeficiency  Vy Hong-Diep Kim, MD, Brenda Reid,
Is 9 more than 2 also in allergic airway inflammation?
Intramuscular Versus Intravenous Immunoglobulin Replacement Therapy and Measurement of Immunoglobulin Levels During Immunoglobulin Replacement Therapy 
Jonathan A. Bernstein, MD, David M. Lang, MD, David A. Khan, MD 
Transplacental maternal engraftment and posttransplantation graft-versus-host disease in children with severe combined immunodeficiency  Justin Wahlstrom,
An Infant with Atopic Dermatitis and Itching After Ingestion of Milk
Long-term immune reconstitution and clinical outcome after stem cell transplantation for severe T-cell immunodeficiency  Evelina Mazzolari, MD, Concetta.
Rising prevalence of asthma is sex-specific in a US farming population
Lieuwe D. Bos, MSc, PhD, Peter J. Sterk, MD, PhD, Stephen J
Gut microbiome variations during hematopoietic stem cell transplant in severe combined immunodeficiency  Jonathan P. Lane, MBBS, Christopher J. Stewart,
Peter M. Wolfgram, MD, David B. Allen, MD 
Etiology of asthma exacerbations
Asthma treatment and asthma prevention: A tale of 2 parallel pathways
Practice pattern changes and improvements in hematopoietic cell transplantation for primary immunodeficiencies  Rebecca A. Marsh, MD, Kyle M. Hebert,
Debra J. Palmer, PhD, Thomas R. Sullivan, BMa&CompSc(Hons), Michael S
Phillip Lieberman, MD, Michael Tankersley, MD 
Time for a paradigm shift in asthma treatment: From relieving bronchospasm to controlling systemic inflammation  Leif Bjermer, MD  Journal of Allergy.
Staphylococcus aureus colonization is associated with wheeze and asthma among US children and young adults  Meghan F. Davis, PhD, Roger D. Peng, PhD,
Food allergy in patients with primary immunodeficiency diseases: Prevalence within the US Immunodeficiency Network (USIDNET)  Karen S. Tuano, MD, Jordan.
Long-term outcomes of nonconditioned patients with severe combined immunodeficiency transplanted with HLA-identical or haploidentical bone marrow depleted.
Reduced risk of peanut sensitization following exposure through breast-feeding and early peanut introduction  Tracy J. Pitt, MD, Allan B. Becker, MD,
Phillip Lieberman, MD, David Golden, MD 
Food allergy: A review and update on epidemiology, pathogenesis, diagnosis, prevention, and management  Scott H. Sicherer, MD, Hugh A. Sampson, MD  Journal.
Biosimilars and drug development in allergic and immunologic diseases
Christian Hennig, MD, Christine Happle, MD, Gesine Hansen, MD 
Fiscal Implications of Newborn Screening in the Diagnosis of Severe Combined Immunodeficiency  Catherine Kubiak, MD, Soma Jyonouchi, MD, Caroline Kuo,
Daphne Koinis-Mitchell, PhD, Timothy Craig, DO, Cynthia A
Claus Bachert, MD, PhD, Cezmi A. Akdis, MD 
William T. Shearer, MD, PhD, Alain Fischer, MD, PhD 
What is an “eosinophilic phenotype” of asthma?
Cephalosporin Side Chain Cross-reactivity
Mechanism-Based Precision Therapy for the Treatment of Primary Immunodeficiency and Primary Immunodysregulatory Diseases  Jennifer W. Leiding, MD, Lisa.
Granulomatous-lymphocytic Interstitial Lung Disease in a Patient with Common Variable Immunodeficiency  Phil Lieberman, MD, John Routes, MD  The Journal.
H. William Kelly, PharmD  Journal of Allergy and Clinical Immunology 
Personalized asthma therapy in blacks—the role of genetic ancestry
Autophagy: Nobel Prize 2016 and allergy and asthma research
Food allergy: Epidemiology, pathogenesis, diagnosis, and treatment
Advances in the approach to the patient with food allergy
Diagnosis and management of early asthma in preschool-aged children
Geographic variability in childhood asthma prevalence in Chicago
Corinne A. Keet, MD, MS, Wayne G. Shreffler, MD, PhD, Roger D
Prevention of food allergy: Beyond peanut
The Editors' Choice Journal of Allergy and Clinical Immunology
Practice Notes from the AAAI
Anaphylaxis Journal of Allergy and Clinical Immunology
Change in visual analog scale score in a pragmatic randomized cluster trial of allergic rhinitis  Philippe-Jean Bousquet, MD, Christophe Combescure, PhD,
Measles and immunomodulation
The Editors' Choice Journal of Allergy and Clinical Immunology
Macrolide antibiotics and asthma treatment
Immune pathomechanism of drug hypersensitivity reactions
Statistical issues in clinical trials that involve the double-blind, placebo-controlled food challenge  Vernon M. Chinchilli, PhD, Laura Fisher, MD, Timothy.
Asthma: The past, future, environment, and costs
Environmental factors and eosinophilic esophagitis
Advances in pediatric asthma in 2007
Negative affect, medication adherence, and asthma control in children
Safety and efficacy of repeated monthly carboplatin desensitization
Natural history of cow’s milk allergy
Primary prevention of asthma and allergy
Presentation transcript:

Treatment of infants identified as having severe combined immunodeficiency by means of newborn screening  Morna J. Dorsey, MD, MMSc, Christopher C. Dvorak, MD, Morton J. Cowan, MD, Jennifer M. Puck, MD  Journal of Allergy and Clinical Immunology  Volume 139, Issue 3, Pages 733-742 (March 2017) DOI: 10.1016/j.jaci.2017.01.005 Copyright © 2017 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig 1 Identification of T-cell immune defects by means of TREC NBS. Primary immune defects can also be diagnosed based on a history of affected family members or clinical features. Journal of Allergy and Clinical Immunology 2017 139, 733-742DOI: (10.1016/j.jaci.2017.01.005) Copyright © 2017 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig 2 Donor selection and conditioning for typical SCID. 1Excludes OS and leaky SCID, both of which are classified as atypical SCID for transplant purposes and require at least some conditioning. This also excludes RS-SCID (eg, DCLREC1 and LIG4), for which donor selection and conditioning are individualized to balance risk of rejection versus chemotherapy toxicity. 2GT clinical trials should be considered for X-linked or ADA-SCID when there is no HLA-matched sibling. 3Based on availability, CMV status, donor age, and other variables. 4Non–radiation-sensitive T−B−NK+ SCID generally requires chemotherapy plus serotherapy for unrelated donor transplantation. 5For X-linked and Janus kinase 3 SCID, a maternal donor with serotherapy alone is preferred over a 9/10 unrelated or 6-7/8 cord donor. 6Consider chemotherapy conditioning for enhanced B-cell and/or T-cell reconstitution and to prevent rejection. URD, Unrelated adult donor. Journal of Allergy and Clinical Immunology 2017 139, 733-742DOI: (10.1016/j.jaci.2017.01.005) Copyright © 2017 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Fig 3 Evaluation and management of non-SCID TCL (persistently <1500 CD3 T cells). Continued follow-up is needed to determine the degree and persistence of immune impairment, whether prophylactic therapy is needed, and whether an underlying cause can be found. Journal of Allergy and Clinical Immunology 2017 139, 733-742DOI: (10.1016/j.jaci.2017.01.005) Copyright © 2017 American Academy of Allergy, Asthma & Immunology Terms and Conditions